World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
61
Citations
28900
World Ranking
11089
National Ranking
4794

Overview

Davide Ruggero is affiliated with the University of California, San Francisco in the United States. Their research spans the fields of Biochemistry, Genetics and Molecular Biology, with a significant focus also on Medicine.

Their subfields of study include Molecular Biology, Oncology, Immunology, Pulmonary and Respiratory Medicine, and Radiology, Nuclear Medicine and Imaging.

Davide Ruggero's work centers on several main topics, notably:

  • RNA and protein synthesis mechanisms
  • RNA modifications and cancer
  • RNA Research and Splicing
  • CRISPR and Genetic Engineering
  • Cancer Immunotherapy and Biomarkers
  • Monoclonal and Polyclonal Antibodies Research
  • Ubiquitin and proteasome pathways

The scientist has contributed to a number of recent publications, including:

  • A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing, 2020, bioRxiv (Cold Spring Harbor Laboratory)
  • ERα is an RNA-binding protein sustaining tumor cell survival and drug resistance, 2021, Cell
  • Protein synthesis control in cancer: selectivity and therapeutic targeting, 2022, The EMBO Journal
  • Evolutionarily divergent mTOR remodels translatome for tissue regeneration, 2023, Nature
  • Ferronostics: Measuring Tumoral Ferrous Iron with PET to Predict Sensitivity to Iron-Targeted Cancer Therapies, 2020, Journal of Nuclear Medicine

Frequent coauthors include:

  • Duygu Kuzuoğlu-Öztürk
  • Juan A. Osés-Prieto
  • Maria Barna
  • Joanna Kovalski
  • Hani Goodarzi

Publication venues where Davide Ruggero frequently appears are:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Molecular Cell
  • Molecular Cancer Research
  • Nature
  • Cancer Research

Best Publications

  • A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.

    David E. Gordon;Gwendolyn M. Jang;Mehdi Bouhaddou;Jiewei Xu

  • VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

    Rosandra N. Kaplan;Rebecca D. Riba;Stergios Zacharoulis;Anna H. Bramley

  • The translational landscape of mTOR signalling steers cancer initiation and metastasis

    Andrew C. Hsieh;Yi Liu;Merritt P. Edlind;Nicholas T. Ingolia

  • Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2.

    Morris E Feldman;Beth Apsel;Aino Uotila;Robbie Loewith

  • Does the ribosome translate cancer

    Davide Ruggero;Pier Paolo Pandolfi

  • PML is essential for multiple apoptotic pathways.

    Zhu-Gang Wang;Davide Ruggero;Simona Ronchetti;Sue Zhong

  • The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis.

    Davide Ruggero;Davide Ruggero;Lorenzo Montanaro;Li Ma;Wei Xu

  • IRE1α Cleaves Select microRNAs During ER Stress to Derepress Translation of Proapoptotic Caspase-2

    John-Paul Upton;Likun Wang;Dan Han;Eric S. Wang

  • Autism-related deficits via dysregulated eIF4E-dependent translational control

    Christos G. Gkogkas;Arkady Khoutorsky;Israeli Ran;Emmanouil Rampakakis

  • Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4E.

    Andrew C. Hsieh;Maria Costa;Ornella Zollo;Cole Davis

  • Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification

    Davide Ruggero;Silvia Grisendi;Francesco Piazza;Eduardo Rego;Eduardo Rego

  • Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency.

    Maria Barna;Aya Pusic;Ornella Zollo;Maria Costa

  • Impaired Control of IRES-Mediated Translation in X-Linked Dyskeratosis Congenita

    Andrew Yoon;Guang Peng;Yves Brandenburg;Ornella Zollo

  • ER stress–mediated autophagy promotes Myc-dependent transformation and tumor growth

    Lori S. Hart;John T. Cunningham;Tatini Datta;Souvik Dey

  • Exaggerated translation causes synaptic and behavioural aberrations associated with autism

    Emanuela Santini;Thu N. Huynh;Andrew F. MacAskill;Adam G. Carter

  • Targeting the eIF4F translation initiation complex: a critical nexus for cancer development.

    Jerry Pelletier;Jeremy Graff;Davide Ruggero;Nahum Sonenberg

  • Translational Control in Cancer Etiology

    Davide Ruggero

  • Differential Requirements for eIF4E Dose in Normal Development and Cancer

    Morgan L. Truitt;Crystal S. Conn;Zhen Shi;Xiaming Pang

  • rRNA pseudouridylation defects affect ribosomal ligand binding and translational fidelity from yeast to human cells.

    Karen Jack;Cristian Bellodi;Dori M. Landry;Rachel O. Niederer

  • Translational Control in Cancer

    Nathaniel Robichaud;Nahum Sonenberg;Davide Ruggero;Robert J. Schneider

Frequent Co-Authors

Kevan M. Shokat
Kevan M. Shokat University of California, San Francisco
Sante Tura
Sante Tura University of Bologna
Pier Paolo Pandolfi
Pier Paolo Pandolfi Beth Israel Deaconess Medical Center
Serge Y. Fuchs
Serge Y. Fuchs University of Pennsylvania
Constantinos Koumenis
Constantinos Koumenis University of Pennsylvania
Akiko Shimamura
Akiko Shimamura Harvard University
Nahum Sonenberg
Nahum Sonenberg McGill University
J. Alan Diehl
J. Alan Diehl Case Western Reserve University
David A. Fruman
David A. Fruman University of California, Irvine
Peter R. Carroll
Peter R. Carroll University of California, San Francisco

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Davide Ruggero

Trending Scientists